Posts

FDA's 2027 Budget Proposal: Permanent Rare Disease Vouchers and Expedited Clinical Trial Entry

on

Uncertainty Clouds Finances for Payers and Health Systems in Q2 2025

on

Shrinking Budgets and Rising Targets Pile Pressure on Pharma Marketers: Survey Highlights 2025 Challenges

on

Federally-Funded Cancer Research at a Perilous Crossroads: Deep Cuts Threaten Progress

on

Will Trump's Tax Bill Cut Medicare by $490 Billion? Not Exactly.

on

RFK Jr. Defends HHS Staff Cuts and Reorganization at House and Senate Hearings

on

250 more NIH workers laid off, including cuts at the National Cancer Institute

on

Leaked HHS budget signals $40B in cuts, assumes ACA subsidies expire

on

Massive FDA Staff Cuts Jeopardize Drug and Device Review Processes, Threatening Critical User Fee Programs

on